Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

ATAI ATAI Life Sciences NV

1,73

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 10:00:00

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

0000950170-23-041345.txt

ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more ATAI Life Sciences NV Charts.

ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more ATAI Life Sciences NV Charts.

News ATAI Life Sciences NV

Form 4 - Statement of changes in beneficial ownership of securities
Montag 20 Mai 2024 (13 Stunden vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 15 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 15 Mai 2024 (6 Tage vor) • Edgar (US Regulatory)

atai Life Sciences Reports First Quarter 2024 Financial Results and Corporate Updates
Mittwoch 15 Mai 2024 (6 Tage vor) • GlobeNewswire Inc.

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
Mittwoch 24 April 2024 (4 Wochen vor) • GlobeNewswire Inc.

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
Mittwoch 17 April 2024 (1 Monat vor) • GlobeNewswire Inc.

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
Mittwoch 27 März 2024 (2 Monate vor) • GlobeNewswire Inc.

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
Montag 4 März 2024 (3 Monate vor) • GlobeNewswire Inc.

atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
Mittwoch 28 Februar 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dienstag 13 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 6 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere ATAI Life Sciences NV News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen